Hepatitis C Virus (HCV) Antiviral Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251334 | Category: Medical Care | Pages: 67 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.
This report aims to provide a comprehensive presentation of the global market for Hepatitis C Virus (HCV) Antiviral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis C Virus (HCV) Antiviral. This report contains market size and forecasts of Hepatitis C Virus (HCV) Antiviral in global, including the following market information:
Global Hepatitis C Virus (HCV) Antiviral Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hepatitis C Virus (HCV) Antiviral market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
HCV Antibody Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatitis C Virus (HCV) Antiviral include Roche Diagnostics, Abbott, Siemens, Qiagen, bioMérieux, Bio-Rad Laboratories, Meridian Bioscience, Vista Diagnostics and Biogate Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis C Virus (HCV) Antiviral companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis C Virus (HCV) Antiviral Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hepatitis C Virus (HCV) Antiviral Market Segment Percentages, by Type, 2022 (%)
    HCV Antibody
    HCV Viral Load
    HCV Genotyping
Global Hepatitis C Virus (HCV) Antiviral Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hepatitis C Virus (HCV) Antiviral Market Segment Percentages, by Application, 2022 (%)
    Diagnostic Centers
    Hospitals
    Home Use
Global Hepatitis C Virus (HCV) Antiviral Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hepatitis C Virus (HCV) Antiviral Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis C Virus (HCV) Antiviral revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hepatitis C Virus (HCV) Antiviral revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Roche Diagnostics
    Abbott
    Siemens
    Qiagen
    bioMérieux
    Bio-Rad Laboratories
    Meridian Bioscience
    Vista Diagnostics
    Biogate Laboratories
    J.Mitra & Co. Ltd
    Siemens Medical
    General Biologicals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis C Virus (HCV) Antiviral, market overview.
Chapter 2: Global Hepatitis C Virus (HCV) Antiviral market size in revenue.
Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) Antiviral company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis C Virus (HCV) Antiviral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Hepatitis C Virus (HCV) Antiviral Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hepatitis C Virus (HCV) Antiviral Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hepatitis C Virus (HCV) Antiviral Overall Market Size
    2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size: 2022 VS 2029
    2.2 Global Hepatitis C Virus (HCV) Antiviral Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hepatitis C Virus (HCV) Antiviral Players in Global Market
    3.2 Top Global Hepatitis C Virus (HCV) Antiviral Companies Ranked by Revenue
    3.3 Global Hepatitis C Virus (HCV) Antiviral Revenue by Companies
    3.4 Top 3 and Top 5 Hepatitis C Virus (HCV) Antiviral Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Hepatitis C Virus (HCV) Antiviral Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hepatitis C Virus (HCV) Antiviral Players in Global Market
        3.6.1 List of Global Tier 1 Hepatitis C Virus (HCV) Antiviral Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hepatitis C Virus (HCV) Antiviral Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Hepatitis C Virus (HCV) Antiviral Market Size Markets, 2022 & 2029
        4.1.2 HCV Antibody
        4.1.3 HCV Viral Load
        4.1.4 HCV Genotyping
    4.2 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue & Forecasts
        4.2.1 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2023
        4.2.2 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2024-2029
        4.2.3 By Type - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hepatitis C Virus (HCV) Antiviral Market Size, 2022 & 2029
        5.1.2 Diagnostic Centers
        5.1.3 Hospitals
        5.1.4 Home Use
    5.2 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue & Forecasts
        5.2.1 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2023
        5.2.2 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2024-2029
        5.2.3 By Application - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Hepatitis C Virus (HCV) Antiviral Market Size, 2022 & 2029
    6.2 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue & Forecasts
        6.2.1 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2023
        6.2.2 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue, 2024-2029
        6.2.3 By Region - Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2029
        6.3.2 US Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.3.3 Canada Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.3.4 Mexico Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2029
        6.4.2 Germany Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.4.3 France Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.4.4 U.K. Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.4.5 Italy Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.4.6 Russia Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.4.7 Nordic Countries Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.4.8 Benelux Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2029
        6.5.2 China Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.5.3 Japan Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.5.4 South Korea Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.5.5 Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.5.6 India Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2029
        6.6.2 Brazil Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.6.3 Argentina Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hepatitis C Virus (HCV) Antiviral Revenue, 2018-2029
        6.7.2 Turkey Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.7.3 Israel Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.7.4 Saudi Arabia Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
        6.7.5 UAE Hepatitis C Virus (HCV) Antiviral Market Size, 2018-2029
7 Hepatitis C Virus (HCV) Antiviral Companies Profiles
    7.1 Roche Diagnostics
        7.1.1 Roche Diagnostics Company Summary
        7.1.2 Roche Diagnostics Business Overview
        7.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.1.4 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.1.5 Roche Diagnostics Key News & Latest Developments
    7.2 Abbott
        7.2.1 Abbott Company Summary
        7.2.2 Abbott Business Overview
        7.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.2.4 Abbott Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.2.5 Abbott Key News & Latest Developments
    7.3 Siemens
        7.3.1 Siemens Company Summary
        7.3.2 Siemens Business Overview
        7.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.3.4 Siemens Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.3.5 Siemens Key News & Latest Developments
    7.4 Qiagen
        7.4.1 Qiagen Company Summary
        7.4.2 Qiagen Business Overview
        7.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.4.4 Qiagen Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.4.5 Qiagen Key News & Latest Developments
    7.5 bioMérieux
        7.5.1 bioMérieux Company Summary
        7.5.2 bioMérieux Business Overview
        7.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.5.4 bioMérieux Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.5.5 bioMérieux Key News & Latest Developments
    7.6 Bio-Rad Laboratories
        7.6.1 Bio-Rad Laboratories Company Summary
        7.6.2 Bio-Rad Laboratories Business Overview
        7.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.6.4 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.6.5 Bio-Rad Laboratories Key News & Latest Developments
    7.7 Meridian Bioscience
        7.7.1 Meridian Bioscience Company Summary
        7.7.2 Meridian Bioscience Business Overview
        7.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.7.4 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.7.5 Meridian Bioscience Key News & Latest Developments
    7.8 Vista Diagnostics
        7.8.1 Vista Diagnostics Company Summary
        7.8.2 Vista Diagnostics Business Overview
        7.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.8.4 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.8.5 Vista Diagnostics Key News & Latest Developments
    7.9 Biogate Laboratories
        7.9.1 Biogate Laboratories Company Summary
        7.9.2 Biogate Laboratories Business Overview
        7.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.9.4 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.9.5 Biogate Laboratories Key News & Latest Developments
    7.10 J.Mitra & Co. Ltd
        7.10.1 J.Mitra & Co. Ltd Company Summary
        7.10.2 J.Mitra & Co. Ltd Business Overview
        7.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.10.4 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.10.5 J.Mitra & Co. Ltd Key News & Latest Developments
    7.11 Siemens Medical
        7.11.1 Siemens Medical Company Summary
        7.11.2 Siemens Medical Business Overview
        7.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.11.4 Siemens Medical Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.11.5 Siemens Medical Key News & Latest Developments
    7.12 General Biologicals
        7.12.1 General Biologicals Company Summary
        7.12.2 General Biologicals Business Overview
        7.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Major Product Offerings
        7.12.4 General Biologicals Hepatitis C Virus (HCV) Antiviral Revenue in Global Market (2018-2023)
        7.12.5 General Biologicals Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Hepatitis C Virus (HCV) Antiviral Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?